MicroRNA-204 increases sensitivity of neuroblastoma cells to cisplatin and is associated with a favourable clinical outcome


Correction to: British Journal of Cancer (2012) 107, 967â€“976; doi:10.1038/bjc.2012.356
Upon publication online and in print, the authors realised that a contributor to the original data for this manuscript had been omitted from the authorship of the final paper.
The authors and publishers are now happy to present the complete, full authorship above.
